Azipramine
Chemical compound
- None
- N-Benzyl-2-(6,7-dihydroindolo[1,7-ab][1]benzazepin-1-yl)-N-methylethanamine
- 58503-82-5
N
57529-83-6 (HCl)
- 65468
- 58920
Y
- 1P9L1B4UIC
- ChEMBL2105908
N
- DTXSID10974061
- Interactive image
- c15ccccc1n3c2c(cccc2cc3CCN(Cc4ccccc4)C)CC5
InChI
- InChI=1S/C26H26N2/c1-27(19-20-8-3-2-4-9-20)17-16-24-18-23-12-7-11-22-15-14-21-10-5-6-13-25(21)28(24)26(22)23/h2-13,18H,14-17,19H2,1H3
Y
- Key:GMJAPDJBIOQXSW-UHFFFAOYSA-N
Y
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Azipramine (TQ-86) is a tetracyclic antidepressant (TeCA) which was synthesized and assayed pharmacologically in animals in 1976, but was never marketed.[1]
References
- ^ Triggle DJ (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
- v
- t
- e
Antidepressants (N06A)
Specific reuptake inhibitors and/or receptor modulators | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Miscellaneous | |
---|---|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
![]() | This article about an amine is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e